| abstract |
The present invention relates to a trimebutin-containing sustained-release tablet, and more specifically, it consists of a two-layer structure of the upper layer and the lower layer adjacent to each other, wherein the upper layer and the lower layer include an active ingredient and a hydrophilic sustained-release polyethylene oxide, respectively, There is no problem such as hardness decrease or tableting disorder in the process, and further relates to a trimebutin-containing sustained-release tablet having an excellent dissolution pattern. |